Metronidazole Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Group B Streptococcus Brain Abscess in a Neonate with Bilateral Otorrhea
Conclusion Brain abscess can occur as a sequela of GBS meningitis in neonates, but they are rare. Otogenic infections require prompt evaluation and treatment as they can progress to serious central nervous infections in neonates. [...] Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Thieme eJournals: Table of contents | Abstract | open access Full text (Source: American Journal of Perinatology Reports)
Source: American Journal of Perinatology Reports - April 4, 2024 Category: Perinatology & Neonatology Authors: Spencer, Emily E. Nostrand, Sarah Van Arya, Shreyas Tags: Case Report Source Type: research

115. Rates of Reinfection for Trichomonas vaginalis in Adolescents and Young adults: an Assessment Following the CDC STI Treatment Guidelines in 2021
In 2021, the Centers for Disease Control (CDC) revised the treatment recommendation for Trichomonas vaginalis from a single dose to a 7-day course of metronidazole. Given the high risk of Trichomonas infection in adolescents and young adults (AYA), this study evaluated reinfection rates before and after the change in CDC treatment guidelines. (Source: Journal of Pediatric and Adolescent Gynecology)
Source: Journal of Pediatric and Adolescent Gynecology - April 1, 2024 Category: OBGYN Authors: Radhika Pandit, Yueyang Fei, Alexandra Burnett, Aneesha Cheedalla Source Type: research

Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research